Osteosarcoma Clinical Trials | Memorial Sloan Kettering Cancer Center
One of them is looking at a treatment that boosts the power of the immune system against osteosarcoma that has spread.
MSK Kids has multiple clinical trials assessing new therapies for osteosarcoma. One of them is looking at a treatment that boosts the power of the immune system against osteosarcoma that has spread. This immunotherapy has helped children with a cancer called neuroblastoma. It is our hope that it can benefit children with osteosarcoma, too.
The statement highlights a clinical trial that aims to enhance immune‑system activity against metastatic osteosarcoma, offering a potential new therapeutic option for children with this aggressive bone cancer.
Bizonyítékszint: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Kapcsolódó jelek
- Systemic Therapy for Osteosarcoma and Ewing Sarcoma
- Potential proteins identified to target in osteosarcoma treatment
- Future Directions in the Treatment of Osteosarcoma
- Is There a Role for Mifamurtide in Nonmetastatic High‑Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS‑2) and Spanish Sarcoma Group (GEIS‑33) Trials
- The clinical trial landscape of osteosarcoma: integrating trial data, immunotherapeutic trends, and biomarker insights